News Focus
News Focus
Post# of 257310
Next 10
Followers 843
Posts 122821
Boards Moderated 10
Alias Born 09/05/2002

Re: Double_Bagel post# 178683

Thursday, 10/09/2014 4:31:26 PM

Thursday, October 09, 2014 4:31:26 PM

Post# of 257310
MNTA—Necuparanib (M402) PR on phase-1 portion of phase-1/2 trial in pancreatic cancer:

http://ir.momentapharma.com/releasedetail.cfm?ReleaseID=875538

Reminder: MNTA is holding an R&D Day webcast tomorrow from 8:30am-Noon ET.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today